[The cutaneous risks of vasopressors. Comparative experimental study of noradrenaline and hypertensin].
D000279:Administration, Cutaneous; D000802:Angiotensin Amide / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology*; D012306:Risk; D012867:Skin / Q000494:pharmacology*; D014662:Vasoconstrictor Agents
D014662:Vasoconstrictor Agents; D000802:Angiotensin Amide; D009638:Norepinephrine
HYPERTENSIN/pharmacology; NOREPINEPHRINE/pharmacology; SKIN/pharmacology